Tag Archives: Advanced

Advanced Satellite Data and Monitoring to Transform Disaster Response and Environmental Monitoring in Southeast Asia

Enhanced disaster response, environmental monitoring, agricultural productivity and infrastructure planning has been made available to businesses in Thailand thanks to a new partnership announced between Tokyo-based SAR satellite data and solutions provider, Synspective Inc., and Asia’s leading satellite operator and space technology service provider, Thaicom. Synspective and Thaicom will supply a joint solution to government,… Read More »

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer London UK 22 April 2021 — GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on the company’s Biologics License Application. Jemperli is indicated for the treatment of adult… Read More »

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More »

Advanced keto diet review

What is this? Dieters adhere to a strict calorie high-protein, no-carb diet administered through the tube by a slow-drip pump mechanism. And since the keto diet limits fruits and vegetables, you will undoubtedly need to take a multivitamin to get enough minerals, calcium, and vitamin D. Ketosis is actually a mild form of ketoacidosis. He… Read More »

FDA Approves Opdivo (nivolumab) for the Treatment of Patients with Advanced Esophageal Squamous Cell Carcinoma (ESCC) After Prior Fluoropyrimidine- and Platinum-based Chemotherapy

Print this page PRINCETON, N.J.–(BUSINESS WIRE) June 10, 2020 Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.1 This application was granted… Read More »

Veea Systems and Angel Trains Collaborate to Provide Advanced Digital Functionality for UK Rail Operators and Passengers

Companies Conclude Department for Transport (DfT) Funded Project as Part of ‘First of a Kind: Demonstrating Tomorrow’s Trains Today’ Scheme Bath, UK – 3rd June 2019 – Veea Systems, the company powering an intelligently connected world with a universal platform for IoT and smart edge solutions, and Angel Trains, one of Britain’s leading train leasing… Read More »